179 related articles for article (PubMed ID: 36307366)
21. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis.
Albertsen PC; Hanley JA; Harlan LC; Gilliland FD; Hamilton A; Liff JM; Stanford JL; Stephenson RA
J Urol; 2000 Apr; 163(4):1138-43. PubMed ID: 10737483
[TBL] [Abstract][Full Text] [Related]
22. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Content Analysis of the Characteristics and Expected Impact of Low-Value Services Identified in US Choosing Wisely Recommendations.
Ganguli I; Thakore N; Rosenthal MB; Korenstein D
JAMA Intern Med; 2022 Feb; 182(2):127-133. PubMed ID: 34870673
[TBL] [Abstract][Full Text] [Related]
24. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.
Abrams-Pompe RS; Fanti S; Schoots IG; Moore CM; Turkbey B; Vickers AJ; Walz J; Steuber T; Eastham JA
Eur Urol Oncol; 2021 Jun; 4(3):370-395. PubMed ID: 33272865
[TBL] [Abstract][Full Text] [Related]
25. Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis.
Papa N; Perera M; Murphy DG; Lawrentschuk N; Evans M; Millar JL; Bolton D
J Med Imaging Radiat Oncol; 2021 Oct; 65(6):649-654. PubMed ID: 33666330
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.
Lenis AT; Pooli A; Lec PM; Sadun TY; Johnson DC; Lebacle C; Fendler WP; Eiber M; Czernin J; Reiter RE; Calais J
Eur Urol Oncol; 2022 Oct; 5(5):544-552. PubMed ID: 32958451
[TBL] [Abstract][Full Text] [Related]
27. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
28. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC;
Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402
[TBL] [Abstract][Full Text] [Related]
29. Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelines.
Abraham N; Wan F; Montagnet C; Wong YN; Armstrong K
J Urol; 2007 Jul; 178(1):82-7; discussion 87. PubMed ID: 17499294
[TBL] [Abstract][Full Text] [Related]
30. Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative.
Miles RC; Lee CI; Sun Q; Bansal A; Lyman GH; Specht JM; Fedorenko CR; Greenwood-Hickman MA; Ramsey SD; Lee JM
J Natl Compr Canc Netw; 2019 Jul; 17(7):813-820. PubMed ID: 31319393
[TBL] [Abstract][Full Text] [Related]
31. Small Decline In Low-Value Back Imaging Associated With The 'Choosing Wisely' Campaign, 2012-14.
Hong AS; Ross-Degnan D; Zhang F; Wharam JF
Health Aff (Millwood); 2017 Apr; 36(4):671-679. PubMed ID: 28373333
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Choosing Wisely Interventions on Low-Value Medical Services: A Systematic Review.
Cliff BQ; Avanceña ALV; Hirth RA; Lee SD
Milbank Q; 2021 Dec; 99(4):1024-1058. PubMed ID: 34402553
[TBL] [Abstract][Full Text] [Related]
33. Health disparities and inequities in the utilization of diagnostic imaging for prostate cancer.
Washington C; Deville C
Abdom Radiol (NY); 2020 Dec; 45(12):4090-4096. PubMed ID: 32761404
[TBL] [Abstract][Full Text] [Related]
34. Emergency Physician Knowledge, Attitudes, and Behavior Regarding ACEP's Choosing Wisely Recommendations: A Survey Study.
Lin MP; Nguyen T; Probst MA; Richardson LD; Schuur JD
Acad Emerg Med; 2017 Jun; 24(6):668-675. PubMed ID: 28164409
[TBL] [Abstract][Full Text] [Related]
35. Imaging and evaluation of patients with high-risk prostate cancer.
Bjurlin MA; Rosenkrantz AB; Beltran LS; Raad RA; Taneja SS
Nat Rev Urol; 2015 Nov; 12(11):617-28. PubMed ID: 26481576
[TBL] [Abstract][Full Text] [Related]
36. Patient and family involvement in Choosing Wisely initiatives: a mixed methods study.
de Grood C; Sypes EE; Niven DJ; Clement F; FitzGerald EA; Kupsch S; King-Hunter S; Stelfox HT; Parsons Leigh J
BMC Health Serv Res; 2022 Apr; 22(1):457. PubMed ID: 35392900
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Payment Changes and Choosing Wisely Recommendations for Use of Low-Value Laboratory Tests in the United States and Canada.
Henderson J; Bouck Z; Holleman R; Chu C; Klamerus ML; Santiago R; Bhatia RS; Kerr EA
JAMA Intern Med; 2020 Apr; 180(4):524-531. PubMed ID: 32040158
[TBL] [Abstract][Full Text] [Related]
38. Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer.
Drangsholt S; Walter D; Ciprut S; Lepor A; Sedlander E; Curnyn C; Loeb S; Malloy P; Winn AN; Makarov DV
Urol Oncol; 2019 Feb; 37(2):145-149. PubMed ID: 30578160
[TBL] [Abstract][Full Text] [Related]
39. Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
Neuner JM; Nattinger AB; Yen T; McGinley E; Nattinger M; Pezzin LE
Breast Cancer Res Treat; 2019 Jul; 176(1):205-215. PubMed ID: 30972612
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
